Damian Marron, CEO, Txcell 00:00:00
TxCell develops innovative, cost-effective, personalized T cell-based immunotherapies for severe chronic inflammatory diseases with high medical need and no treatment options.
TxCell develops innovative, cost-effective, personalized T cell-based immunotherapies for severe chronic inflammatory diseases with high medical need and no treatment options.